Impact of ambulatory pharmacist on hospital visits in older adults with epilepsy: A case-control study.

Objective: Older adults have the highest prevalence of epilepsy of any age group. Care in this group is complex because of comorbidities, polypharmacy, and cognitive impairment. We aimed to assess the impact of an ambulatory pharmacist in decreasing hospital visits in this group.

"Brown Bag Clinic": A Pharmacist-led Approach to Reduce Heart Failure Hospital Readmission.

Heart failure (HF) affects approximately 6 million in the United States and despite guideline-directed medical therapy (GDMT), still more than 20% of patients are readmitted within 30 days. This study evaluated the impact of a "pharmacist-led HF Brown Bag Clinic" (BBC) on HF patient outcomes including readmissions and mortality. This retrospective study, conducted at an academic medical center, included adult patients 18 to 89 years old with HF presenting to the BBC 7-14 days post HF hospitalization.

Implementation of an older adult epilepsy clinic utilizing pharmacist services.

Background: Antiseizure medications are commonly associated with adverse effects including behavioral and cognitive issues, drug interactions, idiosyncratic reactions, and long-term complications, which can lead to non-adherence. At the same time, there are limited reports describing multidisciplinary models of epilepsy care that include pharmacists.

Objective: To describe the pharmacist services in an epilepsy clinic for older adults and document the patient care delivered using this design.

Ambulatory care practice in the COVID-19 era: Redesigning clinical services and experiential learning.

The coronavirus disease (COVID-19) has created a variety of challenges for health care professionals, including ambulatory care clinical pharmacists. High-quality remote and minimal-contact care has become a necessity. Ambulatory care clinical pharmacists around the nation have adjusted their practice.